Shared Queries
Symbol Last trade Day %
Price exp growth
EGOH 0.00010USD
LATF 30K%
Close
LATTENO FOOD CORP COM NPV
PNK:LATF
Buy - Act
Last trade date | price 2017-01-09
0.00010USD
Bid | Ask
Min | Max 0.00010USD 0.00010USD
Day chg | % 0.00010USD 8%
Day volume | % 86.82M
1.96K%
BOY | % chg from
0.00010USD
0.00%
SMA50 | % chg from
0.00010USD
SMA200 | % chg from
0.00010USD
52wk high | % chg from
0.0010USD
Average volume
4.21M
1.96K%
Reversal STM | LTM
0%
Beta
-10.00
Short ratio
Value
Market cap
914.00KUSD
Enterprise value
Instrinsic value
304.67KUSD
Price/ Book value
Price/ Intrinsic value
3.00
Main Fundamentals
Price target | %
0.030USD
30K%
Dividend Yield (yr)
0.00%
ROE | CAGR
723%
ROCE | CAGR
904%
Current Ratio | growth
Liabilities/ Equity
Revenue yield (year)
1.68K%
Revenue growth
119%
EBIT growth
1.08K%
EPS yield (year)
EPS yield (avg)
245%
EPS revisions ratio
Dividend yield (year)
0.00%
Dividend yield (avg)
0.00%
Dividend growth
Efficiency
ROE growth
723%
ROCE (year)
ROCE (avg)
904%
ROIC growth
6.88K%
Gross margin
13.06%
EBIT margin
8.80%
Net profit margin
-5.18%
Solvency
Debt / Book value
Debt ratio
Long-term debt ratio growth
-28.29%
Liabilities / Equity
Net Debt / EBITDA
Free Cash Flow / Long-term Debt
Scores
Growth score
71%
Yield score
43%
Financial health score
62%
Asset value score
61%
Ohlson-O score
99.96%
Altman-Z score
0.97
Company score
1.43
Analyst reco
Value
Price / Intrinsic Value
3.00
Price / Book value
Price / Net Net Working Capital
CFO yield on EV
CFO growth
39.99%
FCF yield on Price (year)
117%
FCF yield on Price (avg)
26.83%
FCF growth
407%
Liquidity
Current ratio
Working Capital / Total Assets
Long-term Debt / Working Capital
Show Revenue
in Million USD
year Market Cap / 15 Net Income EBIT Revenue
2011 1.10B -70.00K -66.36K 200.00K
2012 182.80M 80.00K 80.61K 2.36M
2013 77.69M 909.32K 983.10K 15.10M
2014 48.44M 930.18K 1.01M 15.38M
2015 10.97M 930.18K 796.88K 15.38M
2016 914.00K 930.18K 780.54K 15.38M
2017 273.16M 930.18K 772.37K 15.38M
2018 930.18K 768.29K 15.38M
Latteno Food Corp. is an investment portfolio company. The Company, through its subsidiaries, is engaged in the food and beverage industries. The Company focuses on acquiring food products, medical marijuana edibles and related products or services. The Company's wholly owned subsidiary, Latteno Science Corp., conducts research and development of cannabinoids in Central America. The Company's subsidiary, Rx Harvest Collective Inc., allows medical marijuana cultivation and transactions between its patient members and caregiver members. The Company offers LT-512 for erectile dysfunction (ED) treatment.
